9-136898904-C-A

Variant summary

Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PM2PP3

The NM_021138.4(TRAF2):​c.164C>A​(p.Ser55Tyr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000000686 in 1,458,430 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar. Another variant affecting the same amino acid position, but resulting in a different missense (i.e. S55F) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 6.9e-7 ( 0 hom. )

Consequence

TRAF2
NM_021138.4 missense

Scores

2
12
4

Clinical Significance

Not reported in ClinVar

Conservation

PhyloP100: 2.78

Publications

0 publications found
Variant links:
Genes affected
TRAF2 (HGNC:12032): (TNF receptor associated factor 2) The protein encoded by this gene is a member of the TNF receptor associated factor (TRAF) protein family. TRAF proteins associate with, and mediate the signal transduction from members of the TNF receptor superfamily. This protein directly interacts with TNF receptors, and forms a heterodimeric complex with TRAF1. This protein is required for TNF-alpha-mediated activation of MAPK8/JNK and NF-kappaB. The protein complex formed by this protein and TRAF1 interacts with the inhibitor-of-apoptosis proteins (IAPs), and functions as a mediator of the anti-apoptotic signals from TNF receptors. The interaction of this protein with TRADD, a TNF receptor associated apoptotic signal transducer, ensures the recruitment of IAPs for the direct inhibition of caspase activation. BIRC2/c-IAP1, an apoptosis inhibitor possessing ubiquitin ligase activity, can unbiquitinate and induce the degradation of this protein, and thus potentiate TNF-induced apoptosis. Multiple alternatively spliced transcript variants have been found for this gene, but the biological validity of only one transcript has been determined. [provided by RefSeq, Jul 2008]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 3 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.816

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_021138.4. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF2
NM_021138.4
MANE Select
c.164C>Ap.Ser55Tyr
missense
Exon 2 of 11NP_066961.2

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
TRAF2
ENST00000247668.7
TSL:1 MANE Select
c.164C>Ap.Ser55Tyr
missense
Exon 2 of 11ENSP00000247668.2Q12933-1
TRAF2
ENST00000882556.1
c.164C>Ap.Ser55Tyr
missense
Exon 2 of 11ENSP00000552615.1
TRAF2
ENST00000882557.1
c.164C>Ap.Ser55Tyr
missense
Exon 2 of 11ENSP00000552616.1

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD4 exome
AF:
6.86e-7
AC:
1
AN:
1458430
Hom.:
0
Cov.:
31
AF XY:
0.00000138
AC XY:
1
AN XY:
725398
show subpopulations
⚠️ The allele balance in gnomAD version 4 Exomes is significantly skewed from the expected value of 0.5.
African (AFR)
AF:
0.00
AC:
0
AN:
33410
American (AMR)
AF:
0.00
AC:
0
AN:
44430
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
26068
East Asian (EAS)
AF:
0.0000253
AC:
1
AN:
39598
South Asian (SAS)
AF:
0.00
AC:
0
AN:
85844
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
52484
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5302
European-Non Finnish (NFE)
AF:
0.00
AC:
0
AN:
1111036
Other (OTH)
AF:
0.00
AC:
0
AN:
60258
⚠️ The allele balance in gnomAD4 Exomes is highly skewed from 0.5 (p-value = 0), which strongly suggests a high chance of mosaicism in these individuals.
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.225
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33

ClinVar

Not reported in ClinVar

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.31
BayesDel_addAF
Uncertain
0.086
D
BayesDel_noAF
Benign
-0.11
CADD
Uncertain
25
DANN
Uncertain
0.99
DEOGEN2
Uncertain
0.52
D
Eigen
Uncertain
0.40
Eigen_PC
Uncertain
0.37
FATHMM_MKL
Uncertain
0.86
D
LIST_S2
Uncertain
0.88
D
M_CAP
Pathogenic
0.32
D
MetaRNN
Pathogenic
0.82
D
MetaSVM
Uncertain
0.54
D
MutationAssessor
Benign
1.5
L
PhyloP100
2.8
PrimateAI
Uncertain
0.75
T
PROVEAN
Uncertain
-3.4
D
REVEL
Uncertain
0.63
Sift
Benign
0.13
T
Sift4G
Uncertain
0.0030
D
Polyphen
0.99
D
Vest4
0.73
MutPred
0.76
Loss of helix (P = 0.1299)
MVP
0.65
MPC
0.98
ClinPred
0.98
D
GERP RS
4.5
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.1
Varity_R
0.59
gMVP
0.71
Mutation Taster
=26/74
disease causing

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs746610232; hg19: chr9-139793356; API
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.